Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites

被引:0
|
作者
Yamamoto, H
Kishi, T
Lee, CE
Choi, BJ
Fang, H
Hollenberg, AN
Drucker, DJ
Elmquist, JK
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA
[5] Toronto Gen Hosp, Dept Med, Toronto, ON M5G 2C4, Canada
[6] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada
来源
JOURNAL OF NEUROSCIENCE | 2003年 / 23卷 / 07期
关键词
GLP-1; area postrema; tyrosine hydroxylase; blood-brain barrier; insulin; c-Fos; catecholamine neurons; autonomic regulatory system;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glucagon-like peptide-1 (GLP-1) released from the gut is an incretin that stimulates insulin secretion. GLP-1 is also a brain neuropeptide that has diverse central actions, including inhibition of food and water intake, gastric emptying, and stimulation of neuroendocrine responses characteristic of visceral illness. Both intravenous and intracerebroventricular administration of GLP-1 receptor (GLP-1R) agonists increase blood pressure and heart rate and induce Fos-like immunoreactivity (Fos-IR) in autonomic regulatory sites in the rat brain. The area postrema (AP) is a circumventricular organ and has been implicated in processing visceral sensory information. GLP-1Rs are densely expressed in the AP, and peripheral GLP-1R agonists induce Fos-IR in AP neurons to a greater degree than intracerebroventricular administration. Because the AP lacks a blood-brain barrier, we hypothesized that the AP is a key site for peripheral GLP-1 to activate central autonomic regulatory sites. In this study, we found that many tyrosine hydroxylase (TH)-containing neurons in the AP expressed GLP-1Rs and Fos-IR after intravenous GLP-1R agonists. Furthermore, intravenous but not intracerebroventricular GLP-1R agonists induced TH transcription in the AP in vivo. In addition, GLP-1R agonists directly activated TH transcription in an in vitro cell system. Finally, we found that GLP-1-responsive TH neurons in the AP innervate autonomic control sites, including the parabrachial nucleus, nucleus of solitary tract, and ventrolateral medulla. These findings suggest that catecholamine neurons in the AP link peripheral GLP-1 and central autonomic control sites that mediate the diverse neuroendocrine and autonomic actions of peripheral GLP-1.
引用
收藏
页码:2939 / 2946
页数:8
相关论文
共 50 条
  • [1] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [2] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198
  • [3] Glucagon-like peptide-1
    Doyle, ME
    Egan, JM
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 377 - 399
  • [4] Central glucagon-like peptide-1 in the control of feeding
    Gunn, I
    OShea, D
    Turton, MD
    Beak, SA
    Bloom, SR
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (02) : 581 - 584
  • [5] Glucagon-like peptide-1 (GLP-1) action in the mouse area postrema neurons
    Kawatani, Masahiro
    Yamada, Yuichiro
    Kawatani, Masahito
    PEPTIDES, 2018, 107 : 68 - 74
  • [6] Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
    Lutz, Thomas A.
    Osto, Elena
    CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 257 - 263
  • [7] Glucagon-like peptide-1 and satiety
    S. R. Bloom
    Nature, 1997, 385 : 214 - 214
  • [8] Glucagon-Like Peptide-1 and Diabetes
    Monami, Matteo
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [9] Glucagon-like peptide-1 and satiety
    van, Dijk, G.
    Thiele, T.E.
    Seeley, R.J.
    Woods, S.C.
    Bernstein, I.L.
    Bloom, S.R.
    Nature, 1997, 385 (6613)
  • [10] Glucagon-like peptide-1 and satiety
    G. van Dijk
    T. E. Thiele
    R. J. Seeley
    S. C. Woods
    I. L. Bernstein
    Nature, 1997, 385 : 214 - 214